Notice NOT-NS-21-051 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-055 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: About this position We are looking for an enthusiastic and driven Event and Project Officer to join the training team temporarily to support our te Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position The European Bioinformatics Institute (EMBL-EBI) seeks a Phenomics Team Leader to provide leadership for a newly created Phenom Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position We are looking to recruit an enthusiastic software developer to work in the Genetic Data Platform group that is delivering EMBL Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: About this position We are looking to recruit an enthusiastic Bioinformatician to work in the Genetic Data Platform group that is delivering EMBL-E Hinxton, Cambridgeshire, England

Notice NOT-OD-21-102 from the NIH Guide for Grants and Contracts

Notice NOT-AI-21-047 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-096 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-197 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage UG3/UH3 phased cooperative agreement research applications to plan and implement behavioral and social intervention clinical trials.

Funding Opportunity PAR-21-211 from the NIH Guide for Grants and Contracts. Reissue of PAR-18-431. NIMH seeks applications for pilot effectiveness projects to evaluate the preliminary effectiveness of therapeutic and service delivery interventions for the post-acute management of mental health conditions that are matched to the stage of illness in terms of both their focus (e.g., consolidating and maintaining gains from initial treatment, managing residual symptoms/impairment, preventing relapse, promoting adherence and appropriate service use) and intensity/burden. In this pilot phase of effectiveness research, the trial should be designed to evaluate the feasibility, tolerability, acceptability, safety, and potential effectiveness of the approach; to address whether the intervention engages the target(s)/mechanisms(s) that is/are presumed to underlie the intervention effects; and to obtain preliminary data needed as a pre-requisite to a larger-scale effectiveness trial (e.g., comparative effectiveness study, practical trial) designed to definitely test the effectiveness of interventions to improve post-acute outcomes. This FOA supports pilot effectiveness research to evaluate the feasibility, tolerability, acceptability, safety and preliminary indications of effectiveness of post-acute phase intervention approaches and inform the design of definitive effectiveness trials. Support for fully-powered, definitive effectiveness studies focused on post-acute phase interventions is provided via the R01 currently TEMP-11234.

Funding Opportunity PAR-21-210 from the NIH Guide for Grants and Contracts. Reissue of PAR-18-430. NIMH seeks applications for research projects to evaluate the effectiveness of therapeutic and service delivery interventions for the post-acute management of mental health conditions affecting youth, adults, and older adults. This FOA encourages clinical trials to establish the effectiveness and test hypotheses regarding moderators, mediators, and mechanisms of action of post-acute phase therapeutic and services interventions that are matched to the stage of illness in terms of both their focus (e.g., consolidating and maintaining gains from initial treatment, managing residual symptoms/impairment, preventing relapse, promoting adherence and appropriate service use) and intensity/burden for promoting optimal longer-term outcomes. This FOA is intended to support effectiveness trials testing post-acute phase interventions that are statistically powered to provide a definitive answer regarding the study intervention's effectiveness. Support for pilot effectiveness trials to evaluate the initial feasibility, tolerability, acceptability, safety and preliminary indications of effectiveness of post-acute phase intervention approaches is provided via a companion R34 (Currently TEMP-11235)

Funding Opportunity RFA-RM-21-012 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement (FOA) for the Common Fund Program "Illuminating the Druggable Genome" (IDG; https://commonfund.nih.gov/idg/index) is to solicit applications for pilot projects on IDG-eligible understudied proteins (non-olfactory GPCRs, protein kinases, and ion channels) in order to study them beyond what the IDGs Centers can accomplish and to validate and demonstrate the utility of IDG-generated reagents, data, and approaches. Awards will support the generation of additional data and tools around understudied protein(s) identified by the IDG Program to elucidate the function of these proteins in the context of human disease. Data collected and tools generated by these projects will enhance the overall goals of the IDG Program by demonstrating the quality and utility of IDG-generated data and reagents to the scientific community, increasing awareness of the IDG Program through use of IDG-generated resources, and/or extending the characterization of IDG-eligible proteins.

Funding Opportunity PAR-21-185 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Mentoring Activities

Notice NOT-DA-21-042 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-024 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: About this position   We are looking for a Grants Officer to join us at the European Molecular Biology Laboratory – European Bioinformatics Instit Hinxton, Cambridgeshire, England

Notice NOT-RM-21-019 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-098 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-21-214 from the NIH Guide for Grants and Contracts. Provide short-term training experiences to faculty members from diverse backgrounds that would result in strengthening their ability to perform independent research in genomics. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Under this FOA candidates are permitted to propose a research experience in a clinical trial led by a mentor or co-mentor.